home





























 


















 






















hrsa

participating institutions:
Johns Hopkins University AIDS Service, New York State DOH AIDS Institute, The CORE Center, Cook County Hospital



NEWS AND NEW DEVELOPMENTS



Association of Cancer with AIDS-Related Immunosuppression in Adults [Frisch M, et al. JAMA 2001;285:1736]: This report from the "AIDS-Cancer Match Registry Study Group" examines the frequency of cancer as reported to the Cancer Registry in the U.S. from 1978 to 1996. There is a separate analysis of AIDS-defining cancers (KS, non-Hodgkin lymphoma, and cervical cancer), which accounted for 30,853 of the 35,278 (87%) cancers reported. The results were reported for the relative rate of the designated cancer reported from 60 months before to 27 months after the diagnosis of AIDS. The RR for KS in men after AIDS was 175.8 and for women was 405.2; for NHL it was 72.8, and for cervical cancer it was 5.2. There were 4,422 non-AIDS-defining cancers reported during the five years before AIDS through 27 months after AIDS. High RRs were found for Hodgkin's disease - 11.5, anal cancer - 32.8, and angiosarcoma - 13.4. The overall RR for non-AIDS-defining cancers was 2.7, which is significantly greater than the rate for the general population (p = <0.001). The details are shown in the following table:

Risk of Cancer in 302,834 Adults with AIDS
1978-96 from 60 Months Before to 27 Months After AIDS
Cancer No. RR
AIDS-defining    
    Kaposi's sarcoma 21,155 177.7*
    Non-Hodgkin lymphoma 9,350 72.8
    Cervical cancer 348 5.2
Non-AIDS-defining 4,422 2.7**
    Leukemia 175 3.6
    Hodgkin's disease 612 11.5**
    Oral cavity 260 3.1
    Lip 20 3.1**
    GI tract 637 2.3
    Anal 221 33.8
    Larynx 118 2.8
    Lung 808 4.5**
    Breast 143 1.1
    Angiosarcoma 23 13.4
    Male genital tract 328 1.1
    CNS 156 3.5**
* The RR for KS within 27 months after another AIDS-defining diagnosis was 175.8 for men, 267.2 for gay men, and 405.2 for women.
** P <0.05 for correlation with immunosuppression as indicated by pre-AIDS to post AIDS trends in incidence. Thus, CNS tumors were more frequent after AIDS Compared to pre-AIDS, which the authors attributed to Immunosuppression as a predisposing factor.

Comment: These results largely reflect the experience with cancer in HIV-infected persons in the pre-HAART era. One of the major goals of this project was to determine the potential importance of immunosuppression on cancer rates. The strongest association for a non-AIDS-defining cancer is with Hodgkin's disease, which showed a RR of 11.5 and with HPV-associated cancers including anal cancer and lip cancer. Breast cancer was the only cancer to show a significant decrease in RR. The conclusion is that most non-AIDS-defining cancers are not associated with advancing immunosuppression, although Hodgkin's disease is the notable exception.
p
osted 4/13/2001





Copyright © 2001-2002. The National AIDS Education and Training Centers Program on behalf of its AETC National Resource Center. All rights reserved.

Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained in this site because no single reference or service can take the place of medical training, education, and experience. Consumers are cautioned that this site is not intended to provide medical advice about any specific medical condition they may have or treatment they may need, and they are encouraged to call or see their physician or other health care provider promptly with any health related questions they may have.